|
LV5753A4
|
|
The environment for the use of pharmaceutical formulations of labile substances for perforation
|
|
LV5757A4
|
|
New long-lasting pharmaceutical preparations
|
|
LV5750A4
|
|
Adjustable peeling granules with glass or silicon dioxide core
|
|
LV5752A4
|
|
Pharmaceutical preparation and method for its production
|
|
HK11494A
|
|
New drug preparation with controlled release of the active compound,and a method for the manufacture thereof
|
|
SG8094G
|
|
New drug preparation with controlled release of the active compound, and a method for the manufacture thereof
|
|
LT2310B
|
|
Materials for the adjustment of the regulatory active compound
|
|
LT2256B
|
|
The talk of the tablet
|
|
LV5395A3
|
|
Satisfaction of the tables
|
|
LV5393A3
|
|
A retraction to pellet extraction
|
|
LV5489A3
|
|
Attempt to obtain benzimidazole derivatives or their islands
|
|
LV5473A3
|
|
Attempt to obtain pyridine derivatives
|
|
LV5472A3
|
|
Attempt to obtain pyridine derivatives
|
|
FI930337A0
|
|
N-alkyl-n- (alkylthioalkyl) aminderivat anvaendbara som mellanprodukter
|
|
IL103741D0
|
|
Amino compounds and their preparation
|
|
HRP920593A2
|
|
New drug preparation
|
|
HRP920590A2
|
|
New pharmaceutical preparation
|
|
US5246714A
|
|
Drug preparation
|
|
US5270056A
|
|
Particle having a dyed coke indicator and a pharmaceutical coating for parenteral administration of the pharmaceutical
|
|
JO1661B1
|
|
Therapeutically active fluoro substituted binzimidazoles process for their preparation as well as use
|
